| Home  | About ScienceAsia  | Publication charge  | Advertise with us  | Subscription for printed version  | Contact us  
Editorial Board
Journal Policy
Instructions for Authors
Online submission
Author Login
Reviewer Login
Volume 48 Number 6
Volume 48 Number 5
Volume 48 Number 4
Volume 48 Number 3
Volume 48 Number 2
Volume 48S Number 1
Earlier issues
Volume 45 Number 2 Volume 45 Number 3 Volume 45 Number 4

previous article next article

Research articles

ScienceAsia 45 (2019): 221-228 |doi: 10.2306/scienceasia1513-1874.2019.45.221

Antimalarial and β-hematin formation inhibitory activities of chromone derivatives

Chirattikan Maicheena, Jiraporn Ungwitayatornb,*

ABSTRACT:     A series of chromone compounds were evaluated as new potential antimalarial agents using in vitro antimalarial activity assay. The most potent compound 36 with an IC50 of 0.95 μM was shown to be more potent than primaquine and tafenoquine (IC50 2.41 and 1.95 μM, respectively). β-Hematin formation inhibitory activity test and stoichiometry determination have also been performed to investigate the preliminary mechanism of antimalarial activity of the studied compounds. Compounds 23-28 (IC50 1.41, 1.76, 2.30, 2.54, 4.60, and 3.69 μM, respectively) displayed greater β-hematin formation inhibitory activity than chloroquine, dihydroartemisinin, and mefloquine (IC50 25.04, 18.04, 15.78 μM, respectively). Compounds 3, 4, 23, 24, 27, 36, 38, and 43 showed high potency in both antimalarial and β-hematin formation assays. Job's plots indicated that compounds showing high β-hematin formation inhibitory activity formed stable complexes with the same stoichiometric ratio of chromone:heme = 1:2 as chloroquine. This study opens up the possibility of development of chromone derivatives as new antimalarials targeting β-hematin formation.

Download PDF

156 Downloads 1101 Views

a Faculty of Pharmacy, Huachiew Chalermprakiet University, Samut Prakarn 10540 Thailand
b Faculty of Pharmacy, Mahidol University, Bangkok 10400 Thailand

* Corresponding author, E-mail: jiraporn.ung@mahidol.ac.th

Received 5 Feb 2019, Accepted 24 May 2019